INS and metabolic dysfunction-associated steatotic liver disease: These results suggest that the observed impairment in glucose clearance is not driven by dysregulation of muscular or WAT insulin signaling, which contrasts with the known emergence of insulin resistance in skeletal muscle [47, 48] and adipose tissue [49] in NAFLD.